


The Fund aims to achieve a long-term return, in excess of the long-term return that is typically achieved from United Kingdom equity markets.
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline | 7.1% |
| ASTRAZENECA PLC | 5.4% |
| BP | 5.2% |
| ROYAL DUTCH SHELL | 4.3% |
| Vodafone | 3.9% |
| HSBC HLDGS | 3.7% |
| Unilever | 3.7% |
| Centrica | 3.6% |
| RSA INSURANCE GROUP PLC | 3.5% |
| NATIONAL GRID | 3.4% |
| Key | % Net Assets |
|---|---|
| 7.1% | |
| 5.4% | |
| 5.2% | |
| 4.3% | |
| 78% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 01/02/1972 |
|---|---|
| Fund Manager | Chris Burvill |
| TER | 1.66 (30-Nov-2010) |
| Minimum Investment | |
|---|---|
| Initial | 1000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.11 |
You are here: research